Replicor is a clinical-stage company developing novel NUCLEIC ACID-BASED POLYMERS (NAPs): oligonucleotides whose antiviral activity is strictly dependent on the polymer chemistry of oligonucleotides which can be preserved independently of the sequence of nucleotides present. NAPs have a very important safety advantage over all other existing oligonucleotide-based drugs such as aptamers, antisense oligonucleotides and siRNA: because NAP’s activity is not sequence dependent, NAPs can be engineered with sequences which retain antiviral activity but which do not have pro-inflammatory activity or off target effects common with other oligonucleotide-based drugs, rendering them safe and well tolerated.
Type
Private
HQ
Montreal, CA
Size (employees)
7 (est)
Replicor is headquartered in Montreal, CA
Report incorrect company information

Replicor Office Locations

Replicor has an office in Montreal
Montreal, CA (HQ)
6100 Royalmount Ave
Show all (1)
Report incorrect company information

Replicor Financials and Metrics

Summary Metrics

Investors

Show all financial metrics
Report incorrect company information

Replicor Online and Social Media Presence

Embed Graph
Report incorrect company information